Clinical Trials on Serious Gram-negative Infections in Italy

Total 217 results

Pfizer
Allergan

Terminated

Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. (NOOR)

Gram-negative Bacterial Infection

United States, Hungary, Slovakia, Taiwan, India, Estonia, Greece, Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial

Helicobacter Pylori Infection

Italy
Catholic University of the Sacred Heart

Unknown

Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study

Helicobacter Pylori Infection

Italy
University of Campania "Luigi Vanvitelli"

Completed

5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection

Helicobacter Pylori Infection

Italy
University of Bari

Unknown

Control of Helicobacter Pylori Infection by Probiotics

Helicobacter Pylori Infection

Italy
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Prevention of Meningococcal Infection

Italy
University of Bari

Recruiting

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. (THD-HP)

Helicobacter Pylori Infection | Antibiotic Resistant Infection | Antibiotic Resistant Strain

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae (FMT-CRE)

Enterobacteriaceae Infections | Multi-antibiotic Resistance

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae (FMT_CRE)

Enterobacteriaceae Infections | Multi-antibiotic Resistance

Italy
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults

Meningococcal Disease

Italy
Mical Paul
European Commission

Completed

Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

Gram-Negative Bacterial Infections

Israel, Greece, Italy
UMC Utrecht
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2) (EXPECT-2)

E. Coli Infection

United States, Italy, United Kingdom, Canada, France, Germany, Japan, Spain
Erasmus Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Dr Cipto Mangunkusumo...

Recruiting

Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study. (SAMPAN)

Nosocomial Infection | Pseudomonas Aeruginosa | Colonization, Asymptomatic

Netherlands, Indonesia, Italy
Novartis Vaccines
Novartis

Completed

A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults

Meningococcal Disease | Meningococcal Meningitis

Italy
St. Bortolo Hospital

Completed

Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis (EUPHAS)

Sepsis | Gram-Negative Bacterial Infections | Septic Shock

Italy
IRCCS Sacro Cuore Don Calabria di Negrar

Not yet recruiting

ENDS (ENDometriosis & FuSobacterium) Unveiling the Contribution of Fusobacterium Infection to the Development of Endometriosis (ENDS)

Endometriosis

Italy
Rabin Medical Center

Completed

Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia

Gram Negative Bacteremia

Israel, Italy
Azienda Ospedaliero, Universitaria Pisana

Unknown

Endotoxin in Gram-negative Septic Shock

Gram Negative Septic Shock

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

Meningococcal Disease

Italy, Poland, Russian Federation, Spain, United Kingdom
University of Turin, Italy

Completed

The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial

Sepsis | Gram-Negative Bacterial Infections

Italy
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Meningococcal Infections

Czechia, Finland, Italy, Poland, Romania, Spain
The University of Queensland
Merck Sharp & Dohme LLC

Withdrawn

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection (MERINO III)

Bacteremia Caused by Gram-Negative Bacteria

Spain, Australia, Singapore, Italy, Saudi Arabia
MJM Bonten
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1) (EXPECT-1)

E.Coli Infections

United States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers

Meningococcal Disease

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant (GITMO-SIGNB)

Gram-Negative Bacterial Infections | Complications of Organ Transplant Stem Cells

Italy
GlaxoSmithKline

Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age

Infections, Meningococcal

Germany, Canada, Australia, Belgium, Italy
GlaxoSmithKline

Active, not recruiting

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Infections, Meningococcal

United States, Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

Clostridioides Difficile Infection Recurrence

Italy
Sanofi Pasteur, a Sanofi Company

Completed

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Healthy Volunteers | Meningococcal Immunisation

Spain, Hungary, Italy, Singapore
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Meningococcal Infections

Belgium, Czech Republic, Germany, Italy, Spain, United Kingdom
Novartis Vaccines

Completed

Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers

Meningococcal Disease

Austria, Finland, Germany, Italy, Czech Republic
Novartis Vaccines

Completed

Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years

Meningococcal Disease | Meningococcal Meningitis

Italy
GlaxoSmithKline

Completed

Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation

Pertussis

Spain, Italy
University of Siena
Merck Sharp & Dohme LLC

Unknown

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

Skin Diseases | Pneumonia | Bacteremia | Urinary Tract Infections | Enterobacteriaceae Infections

Italy
Novartis

Terminated

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Staphylococcal Skin Infections

Italy
Eleonora Nucera

Recruiting

Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students (CROSSWORD)

Latent Tuberculosis | Tuberculosis | Tuberculosis, Pulmonary | Health Care Associated Infection | Tuberculosis Infection

Italy
Novartis Vaccines

Completed

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Meningococcal Disease | Meningococcal Meningitis

Spain, Italy, United Kingdom, Czech Republic
Novartis Vaccines
GlaxoSmithKline

Completed

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Serogroup B Meningococcal Meningitis

Austria, Czechia, Finland, Germany, Italy
Novartis Vaccines

Completed

Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants

Meningococcal Infections | Meningococcal Meningitis

Argentina, Chile, Czech Republic, Hungary, Italy
Rambam Health Care Campus
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Imperial College... and other collaborators

Recruiting

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection (DONATE)

Clostridioides Difficile Infection

Israel, Canada, Hungary, Italy, Lithuania, United Kingdom
University of Palermo

Recruiting

Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks

Familial Mediterranean Fever | Non-celiac Gluten Sensitivity

Italy
Meyer Children's Hospital IRCCS

Recruiting

Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age

Tuberculosis Infection

Italy
Novartis
Novartis Vaccines

Completed

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Meningococcal Meningitis

United States, Italy
Paola Mantegani

Active, not recruiting

Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment (IGRA/MAT-1)

Tuberculosis

Italy
University of Siena
Ministry of Education, Universities and Research, Italy

Completed

Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults (PCV13HIV2011)

HIV Infection | Pneumococcal Infections

Italy
Novartis Vaccines
GlaxoSmithKline

Completed

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Meningococcal Disease | Meningococcal Meningitis

Belgium, Czechia, Germany, Italy, Spain, United Kingdom
ASST Fatebenefratelli Sacco

Unknown

Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists (TNFTB)

Rheumatoid Arthritis | Tuberculosis | Spondylarthritis

Italy
Ospedale San Raffaele

Not yet recruiting

Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis (uLAMTBFIA)

Tuberculosis | Diagnoses Disease

Italy
University of Siena
Catholic University of the Sacred Heart

Withdrawn

Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults

Pneumococcal Infections | HIV

Italy
University of Palermo

Completed

Gluten-related Disorders in Familial Mediterranean Fever Patients

Familial Mediterranean Fever (FMF) | Not-celiac Wheat Sensitivity (NCWS)

Italy

3

Subscribe